ENDRA Life Sciences Inc. (NDRA) Q4 2024 Annual Earnings
NDRA·Reported March 31, 2025·Before market open
ENDRA Life Sciences Inc. reported Q4 2024 revenue of $211.6K. Diluted EPS came in at $-9.40, missed the $-4.10 consensus by $5.30.
Revenue
$211.6K
Diluted EPS
$-9.40missed by $5.30
Consensus: $-4.10
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about ENDRA Life Sciences Inc.'s Q4 2024 earnings report.
ENDRA Life Sciences Inc. (NDRA) reported Q4 2024 earnings on March 31, 2025 before market open.
ENDRA Life Sciences Inc. reported revenue of $211.6K and diluted EPS of $-9.40 for Q4 2024.
EPS missed the consensus estimate of $-4.10 by $5.30.
You can read the 10-K periodic report (0001654954-25-003612) directly on SEC EDGAR. The filing index links above go to sec.gov.